Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Keros Therapeutics Inc (KROS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Keros's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
50.43 -1.94    -3.70%
21:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
50.43
-0.00
-0.00%
21:02:19 - Real-time Data
  • Volume: 271,195
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 50.07 - 52.69
Type:  Equity
Market:  United States
Keros 50.43 -1.94 -3.70%

KROS Balance Sheet

 
Assess the latest Keros Therapeutics Inc balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced KROS Annual Report data, financial summaries and charts are available for Keros Therapeutics Inc investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 463.13 347.29 304.44 334.31
Cash and Short Term Investments 442.44 331.15 287.89 322.03
Cash - - - -
Cash & Equivalents 442.44 331.15 287.89 322.03
Short Term Investments - - - -
Total Receivables, Net 1.78 1.09 0.898 0.964
Accounts Receivables - Trade, Net 0.226 0.143 - -
Total Inventory - - - -
Prepaid Expenses 1.56 1.64 2.52 2.46
Other Current Assets, Total 17.34 13.42 13.12 8.85
Total Assets 485.82 370.02 326.25 356.31
Property/Plant/Equipment, Total - Net 19.43 19.47 19.03 19.1
Property/Plant/Equipment, Total - Gross - 21.19 - -
Accumulated Depreciation, Total - -1.72 - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term 1.55 0.948 0.898 0.964
Other Long Term Assets, Total 3.26 3.26 2.79 2.9
Other Assets, Total 15.56 12.33 12.23 7.89
Total Current Liabilities 18.72 24.37 16.7 16.1
Accounts Payable 4.99 5.45 3.87 4.15
Payable/Accrued - - - -
Accrued Expenses 11.83 17.25 11.79 11.52
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1.05 1 0.611 -
Other Current liabilities, Total 0.855 0.665 0.433 0.43
Total Liabilities 31.87 37.81 30.4 30.05
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 13.15 13.44 13.7 13.95
Total Equity 453.95 332.21 295.84 326.26
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.003 0.003 0.003 0.003
Additional Paid-In Capital 878.48 713.64 637.02 628
Retained Earnings (Accumulated Deficit) -424.54 -381.43 -341.18 -301.74
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 485.82 370.02 326.25 356.31
Total Common Shares Outstanding 36.07 31.84 29.68 29.66
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KROS Price Commentary

Write your thoughts about Keros Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email